cbdMD, Inc. (NYSEAMERICAN:YCBD – Get Free Report) saw a significant decline in short interest during the month of June. As of June 15th, there was short interest totalling 142,300 shares, a decline of 13.1% from the May 31st total of 163,700 shares. Currently, 4.5% of the shares of the company are short sold. Based on an average daily trading volume, of 198,300 shares, the days-to-cover ratio is currently 0.7 days.
Institutional Investors Weigh In On cbdMD
A hedge fund recently raised its stake in cbdMD stock. AXS Investments LLC boosted its holdings in cbdMD, Inc. (NYSEAMERICAN:YCBD – Free Report) by 42.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 91,204 shares of the company’s stock after acquiring an additional 27,017 shares during the quarter. AXS Investments LLC owned about 2.99% of cbdMD worth $95,000 as of its most recent filing with the SEC. Institutional investors own 7.18% of the company’s stock.
cbdMD Price Performance
NYSEAMERICAN YCBD traded down $0.02 on Tuesday, reaching $0.56. The stock had a trading volume of 18,692 shares, compared to its average volume of 220,278. cbdMD has a 12-month low of $0.56 and a 12-month high of $1.73. The company has a current ratio of 1.07, a quick ratio of 0.61 and a debt-to-equity ratio of 0.88. The stock has a market cap of $2.17 million, a P/E ratio of -0.05 and a beta of 2.01.
About cbdMD
cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.
See Also
- Five stocks we like better than cbdMD
- What is the Shanghai Stock Exchange Composite Index?
- RXO Shares Surge Following New Acquisition Deal
- What Are Growth Stocks and Investing in Them
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Stock Market Sectors: What Are They and How Many Are There?
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.